James Ziegler was appointed as the Executive Vice President and Chief Commercial Officer of Geron Corporation on September 9, 2024. With an extensive background in the biopharmaceutical industry, Ziegler brings a wealth of experience to his new role at Geron. Prior to joining Geron, he served as the Senior Vice President of Global Commercial Operations at a leading oncology-focused biotech company, where he was instrumental in launching several successful cancer therapies. His strategic vision and leadership were pivotal in expanding the company's global footprint and enhancing its commercial capabilities. Ziegler's career is marked by notable achievements in driving commercial growth and operational excellence. He holds an MBA from a top-tier business school and has a proven track record of developing and executing effective commercialization strategies. At his previous company, he led a team that achieved record-breaking sales and significantly improved patient access to innovative treatments. His expertise in oncology and deep understanding of market dynamics make him a valuable asset to Geron as the company advances its pipeline of novel therapeutics. In his role as Executive Vice President and Chief Commercial Officer at Geron, Ziegler is responsible for overseeing the company's commercial strategy and operations. His primary focus will be on preparing for the potential launch of Geron's lead product candidate, which is currently in late-stage clinical trials. Ziegler's leadership will be crucial in navigating the complexities of bringing new therapies to market, ensuring that Geron can effectively meet the needs of patients and healthcare providers. His strategic insights and commitment to excellence are expected to play a key role in Geron's future success.